Skip to content

FP7

MIP-DILI

Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury

Programme
Seventh Framework Programme
Started
Ends
Duration
62 months
Total cost
EUR 32,319,866
EU contribution
EUR 15,335,538
Participants
28 from 10 countries
Topic
FP7_IMI-JU-03-2010-01
Grant agreement
115336

Coordinated by Astrazeneca AB (SESweden).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
Astrazeneca ABSESwedenCoordinatorNot statedPIC (1.00)
Interface EuropeBEBelgiumParticipantEUR 725,580PIC (1.00)
Janssen Pharmaceutica NVBEBelgiumParticipantNot statedPIC (1.00)
Ucb BiopharmaBEBelgiumParticipantNot statedPIC (1.00)
Abbvie Deutschland GmbH & Co KGDEGermanyParticipantNot statedPIC (1.00)
Albert-Ludwigs-Universitaet FreiburgDEGermanyParticipantEUR 412,663known name (0.97)
Deutsches Krebsforschungszentrum HeidelbergDEGermanyParticipantEUR 956,615known name (0.95)
Klinikum der Technischen Universität München (Tum Klinikum)DEGermanyParticipantEUR 837,312known name (0.97)
Merck Kommanditgesellschaft Auf AktienDEGermanyParticipantNot statedPIC (1.00)
Universitatsklinikum BonnDEGermanyParticipantEUR 602,463known name (0.95)
H. Lundbeck AsDKDenmarkParticipantNot statedPIC (1.00)
Orion OYJFIFinlandParticipantNot statedPIC (1.00)
Institut de Recherches Internationales ServierFRFranceParticipantNot statedPIC (1.00)
KaLy-CellFRFranceParticipantEUR 1,302,043PIC (1.00)
Sanofi-Aventis Recherche & DeveloppementFRFranceParticipantNot statedPIC (1.00)
Universite de Rennes iFRFranceParticipantEUR 886,114PIC (1.00)
CXR Biosciences LimitedGBUnited KingdomParticipantEUR 471,939PIC (1.00)
Eli Lilly and Company LtdGBUnited KingdomParticipantNot statedPIC (1.00)
Glaxosmithkline Research & Development LimitedGBUnited KingdomParticipantNot statedPIC (1.00)
Lhasa LimitedGBUnited KingdomParticipantEUR 552,494PIC (1.00)
The University of LiverpoolGBUnited KingdomParticipantEUR 2,863,103PIC (1.00)
Solvo Biotechnology ZrtHUHungaryParticipantEUR 477,128PIC (1.00)
Stichting VuNLNetherlandsParticipantEUR 1,149,061known name (0.95)
Universiteit LeidenNLNetherlandsParticipantEUR 1,087,035known name (0.95)
Universiteit UtrechtNLNetherlandsParticipantEUR 536,422known name (0.95)
Karolinska InstitutetSESwedenParticipantEUR 1,548,817known name (0.95)
Takara Bio Europe ABSESwedenParticipantEUR 926,749PIC (1.00)
Bristol-Myers Squibb Company CorpUSUnited StatesParticipantNot statedPIC (1.00)

Changes of the consortium

First seen on with 28 participants from 10 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.